https://orcid.org/0000-0002-2572-2611
References
- Henley SJ, Ward EM, Scott S, et al. Annual report to the nation on the status of cancer, part I: national cancer statistics. Cancer. 2020;126(10):2225–2249.
- Grossman HB, Natale RB, Tangen CM, et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med. 2003;349(9):859–866.
- Zargar-Shoshtari K, Zargar H, Lotan Y, et al. A multi-institutional analysis of outcomes of patients with clinically node positive urothelial bladder cancer treated with induction chemotherapy and radical cystectomy. J Urol. 2016;195(1):53–59.
- Moschini M, Mattei A, Cornelius J, et al. Surgical treatment for clinical node-positive bladder cancer patients treated with radical cystectomy without neoadjuvant chemotherapy. World J Urol. 2018;36(4):639–644.
- Galsky MD, Stensland K, Sfakianos JP, et al. Comparative effectiveness of treatment strategies for bladder cancer with clinical evidence of regional lymph node involvement. J clin oncol. 2016;34(22):2627.
- Ho PL, Willis DL, Patil J, et al. Outcome of patients with clinically node-positive bladder cancer undergoing consolidative surgery after preoperative chemotherapy: The MD Anderson Cancer Center Experience. Urologic oncology: seminars and original investigations. 2016;34(2):59.
- Staník M, Poprach A, Zapletalová M, et al. Comparison of different treatment modalities outcomes in clinically node-positive bladder cancer: analysis of a population-based cancer registry. Clin Genitourin Cancer. 2019;17(4):e759–e767.
- National Cancer Database. [ cited 2021 March 28]. Available from: https://www-facs-org.wvu.idm.oclc.org/quality-programs/cancer/ncdb
- Tan MP, Harris V, Warren-Oseni K, et al. The intensity-modulated pelvic node and bladder radiotherapy (IMPART) trial: a phase II single-centre prospective study. Clin Oncol. 2020;32(2):93–100.